Lucid Diagnostics Inc.
LUCD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,211,000 | $1,163 | $828 | $1,197 |
| % Growth | 104,027.3% | 40.5% | -30.8% | – |
| Cost of Goods Sold | $1,697,000 | $1,785 | $1,551 | $2,145 |
| Gross Profit | -$486,000 | -$622 | -$723 | -$948 |
| % Margin | -40.1% | -53.5% | -87.3% | -79.2% |
| R&D Expenses | $1,272,000 | $1,255 | $1,428 | $1,453 |
| G&A Expenses | $5,605,000 | $5,617,000 | $6,162 | $5,864 |
| SG&A Expenses | $9,896,000 | $9,624,000 | $10,231 | $9,868 |
| Sales & Mktg Exp. | $4,291,000 | $4,007,000 | $4,069 | $4,004 |
| Other Operating Expenses | $105,000 | -$9,614,493 | $105 | $106 |
| Operating Expenses | $11,273,000 | $10,762 | $11,764 | $11,427 |
| Operating Income | -$11,759,000 | -$11,384 | -$12,487 | -$12,375 |
| % Margin | -971% | -978.8% | -1,508.1% | -1,033.8% |
| Other Income/Exp. Net | $1,362,000 | $6,945 | -$14,421 | $834 |
| Pre-Tax Income | -$10,397,000 | -$4,439 | -$26,908 | -$11,541 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10,397,000 | -$4,439 | -$26,908 | -$11,541 |
| % Margin | -858.5% | -381.7% | -3,249.8% | -964.2% |
| EPS | -0.1 | -0.08 | -0.52 | -0.2 |
| % Growth | -25.5% | 84.7% | -160% | – |
| EPS Diluted | -0.1 | -0.08 | -0.52 | -0.2 |
| Weighted Avg Shares Out | 108,176 | 98,989 | 68,796 | 57,705 |
| Weighted Avg Shares Out Dil | 108,176 | 98,989 | 68,796 | 57,705 |
| Supplemental Information | – | – | – | – |
| Interest Income | $101,000 | $110 | $66 | $66 |
| Interest Expense | $2,000 | $6 | $9 | $7 |
| Depreciation & Amortization | $440,779 | $222 | $221 | $222 |
| EBITDA | -$9,954,221 | -$4,211 | -$26,678 | -$11,312 |
| % Margin | -822% | -362.1% | -3,222% | -945% |